| Bid Price | 0.65p | High Price | 0.68p |
|---|
| Ask Price | 0.70p | Low Price | 0.68p |
|---|
| Open Price | 0.68p | Spread | 7.14% |
|---|
| Prev Close | 0.68p | Volume | 41,487 |
|---|
Physiomics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 20, 2024 | 0.68 | 0.68 | 0.68 | 0.68 | 41,487 |
| Sep 19, 2024 | 0.68 | 0.65 | 0.65 | 0.68 | 250,109 |
| Sep 18, 2024 | 0.70 | 0.65 | 0.65 | 0.68 | 1,000,000 |
| Sep 17, 2024 | 0.68 | 0.70 | 0.67 | 0.70 | 2,094,856 |
| Sep 16, 2024 | 0.70 | 0.69 | 0.65 | 0.68 | 726,726 |
Physiomics PLC Information
| Name | Physiomics PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDR6W943 | Epic | PYC |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 75,000 | Trading Status | Closed |
|---|
| Shares in Issue | 203.21 m | Prev Close | 0.68p |
|---|
| PE Ratio | | Market Cap | £1.37 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.343729 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 6.471074 | Quick Ratio | 6.471074 |
|---|
Physiomics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 25/07/23 | TOUT | James Millen | CEO | 500,000 @ £0.00 | £0.00 |
| 25/07/23 | TIN | James Millen | CEO | 500,000 @ £0.00 | £0.00 |
| 18/07/23 | TOUT | Christophe Chassagnole | RES | 500,000 @ £0.00 | £0.00 |
| 03/07/23 | PLAC | James Millen | CEO | 500,000 @ £0.00 | £500.00 |
| 22/03/21 | SELL | James Millen | CEO | 2,354 @ £0.00 | £0.00 |
| 22/03/21 | TOUT | James Millen | CEO | 242,287 @ £0.00 | £0.00 |
| 22/03/21 | TIN | James Millen | CEO | 242,287 @ £0.00 | £0.00 |
| 12/08/20 | SELL | James Millen | CEO | 597,332 @ £0.06 | £38,528.00 |
| 05/08/20 | EXR | James Millen | CEO | 1,453,923 @ £0.03 | £36,348.00 |
| 06/07/20 | TOUT | James Millen | CEO | 85,715 @ £0.00 | £0.00 |
Physiomics PLC News
